Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised...

Area of Science:

• Urology
• Oncology
• Health Psychology

Background:

• Prostate cancer screening involves prostate-specific antigen (PSA) testing and often biopsy.
• Understanding men's decision-making processes regarding these procedures is vital for effective patient care.

Purpose of the Study:

• To explore men's decision-making experiences concerning PSA testing and prostate biopsy.
• To identify factors influencing acceptance and refusal of these diagnostic procedures.

Main Methods:

• Qualitative interview study nested within the Prostate Testing for Cancer and Treatment (ProtecT) trial.
• Interviews conducted with 58 men aged 50-69 years who either accepted or refused PSA testing and/or prostate biopsy.

Main Results:

• Most men viewed PSA testing and biopsy as acceptable, irrespective of outcomes.
• Perceptions of low risk for prostate cancer were common among men who responded to or ignored PSA testing invitations, and those who refused biopsy.
• Anxiety about biopsy and misunderstandings regarding urinary symptoms and prostate cancer risk were identified.

Conclusions:

• While PSA testing and biopsy are generally accepted, men's risk perceptions may not always align with reality.
• Tailored information provision is recommended to enhance informed decision-making in prostate cancer screening.